2BBBullish & Bearish
SELLAS Life Sciences Group, Inc. (SLS) trades on NASDAQ. It operates in the Health Care sector, Biotechnology industry. Its current 2BB score is 2 out of 100.
SELLAS Life Sciences Group, Inc.’s current 2BB score is 2 out of 100, built from the signal categories below.
| Signal | Score | Reading |
|---|---|---|
| Activity | 0 | Very Low |
| Momentum | 50 | Stable |
| Financial strength | 49 | Normal |
| Quality | 40 | Normal |
| Risk | 55 | Moderate |
| CEO | Angelos M. Stergiou |
| Founded | 2006 |
| Employees | 13 |
| 52-week range | $1.39 – $15.88 |
| Report date | EPS actual | EPS estimate | Revenue actual | Revenue estimate |
|---|---|---|---|---|
| 2027-03-17 | — | -0.0505 | — | — |
| 2026-11-10 | — | -0.0505 | — | — |
| 2026-08-10 | — | -0.0455 | — | — |
| 2026-05-12 | -0.05 | -0.0404 | — | — |